IJSTR

International Journal of Scientific & Technology Research

IJSTR@Facebook IJSTR@Twitter IJSTR@Linkedin
Home About Us Scope Editorial Board Blog/Latest News Contact Us
CALL FOR PAPERS
AUTHORS
DOWNLOADS
CONTACT
QR CODE
IJSTR-QR Code

IJSTR >> Volume 3- Issue 3, March 2014 Edition



International Journal of Scientific & Technology Research  
International Journal of Scientific & Technology Research

Website: http://www.ijstr.org

ISSN 2277-8616



Over 27% of Type II Diabetic Patients Studied at Parirenyatwa Diabetic Clinic in Zimbabwe Have Evidence of Impaired Renal Function

[Full Text]

 

AUTHOR(S)

Erisi Mafuratidze, Kurai Chako, Heather Phillipo, Danai Tavonga Zhou

 

KEYWORDS

Index Terms: Creatinine, Diabetics, Parirenyatwa, Renal Function, Type II Diabetes mellitus, Urea, Zimbabwe

 

ABSTRACT

Abstract: Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia and is the most prevalent non communicable disease in the world. Progressive kidney damage is one of the major complications of diabetes mellitus and has significant mortality and morbidity. The aim of our study was to analyze renal function in Type II diabetics that have been on treatment for more than 12 months. Our laboratory based cross-sectional study was done on 239 patients who have been diagnosed as Type II diabetics for more than 12 months, who routinely attend the Parirenyatwa Diabetic Clinic. Serum sample were used for urea and creatinine analysis. Of the 239 patients studied, 65 (27.2 %) were found to have elevated values of creatinine and/or urea. Creatinine is usually elevated when the kidneys have lost about 50% of their function. Therefore, the prevalence of impaired renal function found in patients attending Parirenyatwa Diabetic clinic was approximately 27.2%. All patients with impaired renal function were hypertensive. Males had a greater percentage of elevated urea and creatinine levels compared to females. Age and period on treatment were found to be significantly associated with impairment of renal function.

 

REFERENCES

[1]. Deepa, K., Manjunatha goud, B.K., Oinam Sarsina, D., et al (2011); Serum Urea, Creatinine In Relation To Fasting Plasma Glucose Levels In Type 2 Diabetic Patients, International journal of Pharmacy and Biological sciences, 1(3), 279-283

[2]. Alberti, K.G and P.Z Zimmet, (1998): Definition, diagnosis and classification of diabetes mellitus and its complications Part 1, Diagnosis and classification of Diabetes Mellitus, Diabetic Medicine, 15,539-553

[3]. Idonije, B.O., Festus O. and Moluba O. (2011) Research Journal of Medical Sciences, 5(1), 1-3

[4]. Zimmerman B.R. and Walker W.A.(1999): American Diabetes Association Complete Guide to Diabetes. American Diabetes Association;2(1)

[5]. Wild S.H., Roglic G., Sicree R., Green A. and King H(2004): Global Burden of Diabetes mellitus in the Year 2000. [online] Available from: http://www3.who. int/whosis/menu.cfm?path=evidence,burden,burden—gbd 2000 docs&language=english

[6]. Mehta R.S., Karki P. and Sharma S.K. (2006): Risk factors, associated health problems, reasons for admission and knowledge profile of diabetes patients admitted in BPKIHS. Kathmandu University Medical Journal; 4(1), 11-3.

[7]. http://www.mohcw.gov.zw/index.php/communicable-diseases

[8]. Shoback, David G. G and Dolores (2011). Greenspan's basic & clinical endocrinology,9(1),17

[9]. J. Mayfield(1998): Diagnosis and Classification of Diabetes mellitus: New Criteria, American Family Physician; 58(6),1355-1365

[10]. Mittal A, Sathian B, Kumar A, et al , (2010): Diabetes mellitus as a Potential Risk Factor for Renal Disease among Nepalese, Nepal Journal of Epidemiology; 1(1), 22-25

[11]. Zimmet P, Alberti K.G and Shaw J.(2001): Global and societal implications of the diabetes epidemic. Nature; 414 (6865):782-7.

[12]. (1998): Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch International Medicines, 158, 1855–1867.

[13]. Rehman, G., Khan S.A and M. Hamayun. (2005): Studies of Diabetic Nephropathy and secondary disease in type 2 diabetes. International Journal of Diabetes Ctries, 25:25-29

[14]. Shera, A.S., Jawad, F., Maqsood, A., et al. (2004): Prevalence of chronic complications and associated factors in type 2 diabetes. Journal of Pakistan Medicine Association, 54: 54-59,

[15]. McClellan, W. (2009): The kidneys and how they work. National Kidney and Urologic Disease Information Clearing House, 09, 3195 - 3200.

[16]. Glodny, B., Unterholzner, V. and Taferner, B. (2009): Normal kidney size and its influencing factors. British Medical Council: Urology, 9, 19 - 22.

[17]. Emmanouel, D. S., Lindheimer, M. D. and Katz, A. I. (2000): Role of the kidney in hormone metabolism and its implications in clinical medicine. Journal of Molecular Medicine, 58(19), 1005 - 1012.

[18]. Swierzewski, S. J. (2001): Chronic Renal Failure overview, types of Chronic Renal Failure. Journal of Health Communities, 4, 4312 - 4315.

[19]. Fioretto, P., Bruseghin, M., Berto, I., et al (2006): Renal protection in diabetes: Role of glycemic control. Journal of American Society Nephropathy, 17(4),S86-9.

[20]. Excerpts from the United States Renal Data Systems 2002 annual report (2003): Atlas of end-stage renal disease in the United States. American Journal of Kidney Disease. ;41(2),v–ix,S7–254.

[21]. Alrawahi, A.H., Rizvi, S.G.A., Al-Riyami, D., Al-Anqoodi, Z. (2012); Prevalence and Risk Factors of Diabetic Nephropathy in Omani Type 2 Diabetics in Al-Dakhiliyah Region. Oman Medical Journals; 27(3), 212-216.

[22]. Micah, L. and Thorp, D.O., (2005): Diabetic Nephropathy: Common Questions American Family Physician; 72(01):96-99.

[23]. Puepet, F.H., Agaba, E.I. and Chuhwak, E.K., (2003): Some metabolic abnormalities in type 2 diabetic patients in Jos, north central Nigeria. Nigeria Journal of Medicine, 12(4), 193-7

[24]. Kamenov, Z.A., Rumyana, A.P., Rumyana, T.G. (2010): Earlier development of Diabetic Nephropathyin men than womenwith Type II Diabetic mellitus, Gend Medicines, 7(6), 600-615

[25]. Evans, N. and Forsyth, E. (2004); End-Stage Renal Disease in People With Type 2 Diabetes: Systemic Manifestations and Exercise Implications, Physical Therapy, 84(5), 454-463.

[26]. Fawcett, J.K. and Scott, J.E. (1999): A rapid and precise method for the determination of urea. Journal of Clinical Pathology; 13,156-9

[27]. Agarwal, A., Sengar, N.S., Jain, P.K., et al (2011) Nephropathy in newly diagnosed Type 2 diabetics with special stress on the role of hypertension, Association of Physicians; 59(1)

[28]. Ayodele, O.E., Alebiosu, C.O. and Salako, B.L. (2004); Diabetic Nephropathy, a review of the natural history, burden, risk factors and treatment, Journal of the National Medical Association; 96(11), 1445–1454

[29]. Evans, T.C. and Capel, P (2000): Diabetic nephropathy, Clinical Diabetes; 18(1)